Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Comparator Drug Sourcing Market to Expand at 3.5% CAGR from 2023 to 2031|Growth Market Reports

This image opens in the lightbox

News provided by

Growth Market Reports

24 May, 2023, 09:00 GMT

Share this article

Share toX

Share this article

Share toX

PUNE, India, May 24, 2023 /PRNewswire/ -- According to a recent market study published by Growth Market Reports, titled, "Comparator Drug Sourcing Market by End-user (Drug Producers/Manufacturers, CMO, Academic, and Research Institute), and Region: Size, Share, Trends and Opportunity Analysis, 2023-2031", the market size was USD 974 million in 2022 and is expected to reach USD 1327 million expanding at a CAGR of 3.5% by the end of 2031. The market growth is attributed to the increased spending of global pharmaceutical corporations on comparator sourcing to prove the effectiveness of new drugs during trial procedures.


Latest Developments:

In January 2023, Avantor, Inc (NYSE: AVTR) one of the leading companies in the market announced a multi-year supply and services agreement with Catalent, Inc. (NYSE: CTLT). Catalent is a major global firm that works on developing and supplying solutions that enable providing patients with better treatments worldwide. As per the agreement, Avantor is to be the primary provider of various laboratory supplies, production and clinical materials, and services to Catalent.

Key Market Players Profiled in the Report

  • AmerisourceBergen Corporation
  • Avantor, Inc.
  • Clinical Services International (CSI)
  • Clinigen Clinical Supplies Management
  • Intertek Group plc
  • MCKESSON CORPORATION
  • Myonex
  • PHARMA'S ALMANAC
  • Sharp Services, LLC
  • Thermo Fisher Scientific
  • TransCelerate BioPharma Inc.

Download PDF Sample here: https://growthmarketreports.com/request-sample/5063

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the industry's market dynamics. It provides an in-depth analysis of the market segments, including end-user and competitor analysis.

This report also includes a complete analysis of industry players and covers their latest developments, product portfolio, pricing, mergers, acquisitions, and collaborations. Moreover, it provides crucial strategies that are helping market players to expand their market share.

For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/5063

Highlights on the Segments of the Comparator Drug Sourcing Market

On the basis of region, the global comparator drug sourcing market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America is expected to dominate the market during the forecast period. The growth of the market in the region is owing to the availability of advanced technology and facilities for research and development and the increasing number of new drug trials. It is further likely to be supported by increasing spending of pharmaceutical firms on comparator drug sourcing to develop the most effective drugs for preventing chronic diseases.

Asia Pacific is anticipated to be a rapidly growing region in the global market due to rising healthcare needs. The major economies in the region such as China and India have the largest population. The regional population's varying healthcare needs and the need to develop cost-effective drug solutions are expected to support the market growth in the region.

To Buy the Complete Report: https://growthmarketreports.com/report/comparator-drug-sourcing-market-global-industry-analysis

Key Takeaways from the Study:

  • Comparator drug sourcing refers to the procurement of existing drugs for comparing them with newly developed drugs during clinical trials. In the process, instead of comparing the new drug with placebo medications in the trial, its compatibility is actually tested against the similar available drugs in the market.
  • The investment in comparator drugs sourcing is growing by pharmaceutical firms, as there is a need to justify new drugs effectivity and costs against the existing drugs.
  • For a pharma company to claim its drug's superiority in treating certain diseases, the trial requires the inclusion of an active comparator drug. The drug manufacturer is required to select comparator drugs against their new drug, and source and supply to every trial site in an uninterrupted manner.
  • The increasing need to justify the effectiveness and price of newly developed drugs to the stakeholders such as insurance companies, government regulators, and pharmacies is driving the need for comparator drug sourcing across global pharmaceutical research and development establishments.
  • The increasing prevalence of chronic disease diseases including cancer, cardiac, and neurological disorders is driving the development of new drugs, which is fueling the market of comparator drug sourcing, for comparative analysis.
  • The development of drugs against bacterial infection is likely to create opportunities for the market. The COVID-19 pandemic propelled the need for developing effective drugs against various bacterial infections, which has opened opportunities to develop superior drugs.
  • Based on the end-user segment, the market is categorized into drug producers/manufacturers, CMO, academic, and research institutes. Of which, the drug producers/manufacturers segment held a significant share of the market in 2022, and is likely to expand at a rapid CAGR during the forecast period.

Read 164 Pages Research Report with Detailed TOC on "Comparator Drug Sourcing Market by End-user (Drug Producers/Manufacturers, CMO, Academic, and Research Institute), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast, 2023 – 2031"

Get Full Access to this Report: https://growthmarketreports.com/checkout/5063

Key Segments Covered

End-user

  • Drug Producers/Manufacturers
  • CMO
  • Academic and Research Institute
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Other Related Reports:

  • Pharmaceutical Manufacturing Market Segments - by Drug Development Types (Outsource and In-house), Formulations (Tablets, Capsules, Suspensions, Injectable, Powders, Sprays, and Others), Routes of Administration (Oral, Parenteral, Topical, Inhalations, and Others), Therapy Areas (Cardiovascular Diseases, Diabetes, Pain, Respiratory Diseases, Cancer, and Others), Prescriptions (Prescription Medicines and Over-the-counter Medicines), Age Groups (Children & Adolescents, Adults, and Geriatric), Distribution Channels (Retail and Non-retail), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.
  • Global Clinical Trial Supply and Logistics for Pharmaceutical Market by Type (Clinical Trial Packaging Services, Clinical Trial Cold Chain Logistics, Others), By Application (Clinical Trial Manufacturing, Clinical Trial Logistics, and Distributions, Clinical Trial Supply Chain Management), And By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa), Forecast From 2022 To 2030
  • Global Clinical Trials Consumables Market by Type (Plastic Labware, Lab Glassware, Others), By Application (Biopharmaceutical, Medical, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
  • Global Generic Drugs Market by Type (Simple Generic Drugs, Super Generic Drugs, Biosimilars), By Application (CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology, Others), And By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa), Forecast From 2022 To 2030

About Growth Market Reports:

Growth Market Reports provides global enterprises as well as small & medium businesses with unmatched quality of "Market Research Reports" and "Industry Intelligence Solutions". Growth Market Reports has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.

Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, and secondary research & consumer surveys.

Contact:

Alex Mathews 
7th Floor, Siddh Icon,
Baner Road, Pune.
Maharashtra – 411045. India.
Phone: +1 909 414 1393
Email: sales@growthmarketreports.com
Web: https://growthmarketreports.com/
Twitter: https://twitter.com/growth_reports
LinkedIn: https://www.linkedin.com/company/growth-market-report/

Logo: https://mma.prnewswire.com/media/1980656/Growth_Market_Reports_Logo1.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.